idarubicin has been researched along with Cancer of Lung in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (54.17) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cheng, N; Feng, Y; Lai, W; Liu, J; Zhang, L | 1 |
| Hirosue, M; Lehr, CM; Loretz, B; Nafee, N; Wenz, G | 1 |
| Kulpraneet, M; Panichchob, P; Prayongratana, K; Tantisiriwat, W | 1 |
| Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M | 1 |
| Dandekar, P; Jain, R; Koch, M; Lehr, CM; Loretz, B; Melero, A; Stauner, T; Wenz, G | 1 |
| Corona, G; Crivellari, D; Lestuzzi, C; Lombardi, D; Lucenti, A; Magri, MD; Massacesi, C; Sorio, R; Talamini, R; Toffoli, G; Veronesi, A | 1 |
| Alberto, P; Cavalli, F; Joss, RA; Obrecht, JP; Siegenthaler, P; VanHelvoirt, A | 1 |
| Dawson, KM | 1 |
| Cersosimo, RJ | 1 |
| Binaschi, M; Capranico, G; De Isabella, P; Pilotti, S; Pratesi, G; Supino, R; Zunino, F | 1 |
| Bogdanovski, M; McKenzie, IF; Pietersz, GA; Smyth, MJ | 1 |
| Felder, TB; Jeffries, D; Newman, RA; Umsawasdi, T | 1 |
| Blum, R; Green, M; Hochster, H; Liebes, L; Muggia, F; Speyer, JL; Wernz, J | 1 |
| Blum, R; Chang, AY; Donehower, RC; Ettinger, DS; Finkelstein, DM; Green, M; Hahn, RG; Ruckdeschel, JC | 1 |
| Carr, DT; Holoye, PY; Jeffries, D; Umsawasdi, T | 1 |
| Benfield, GF; Cullen, MH; Smith, SR; Woodroffe, CM | 1 |
| Ardizzoni, A; Canobbio, L; De Palma, M; Fusco, V; Ganzina, F; Gulisano, M; Pronzato, P; Repetto, L; Rosso, R | 1 |
| Bell, D; Kefford, R; Levi, J; Presgrave, P; Raghavan, D; Woods, R | 1 |
| Ardizzoni, A; Conte, P; Fusco, V; Gulisano, M; Lionetto, R; Pronzato, P; Repetto, L; Rosso, R | 1 |
| de Vries, EG; Le, TK; Meijer, C; Mulder, NH; Timmer-Bosscha, H; Zijlstra, JG | 1 |
| Banham, SW; Cummings, J; Kaye, SB; Milroy, R | 2 |
| Blum, RH; Green, MD; Hochster, HS; Muggia, FM; Speyer, JL; Wernz, JC | 1 |
| Burke, MT; Casper, ES; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG | 1 |
2 review(s) available for idarubicin and Cancer of Lung
| Article | Year |
|---|---|
Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review.
Topics: Adult; Antibiotics, Antineoplastic; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage; Caspofungin; Cytarabine; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Monocytic, Acute; Lipopeptides; Lung Neoplasms; Male; Pyrimidines; Thailand; Triazoles; Voriconazole | 2008 |
Idarubicin: an anthracycline antineoplastic agent.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Cytarabine; Drug Labeling; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
3 trial(s) available for idarubicin and Cancer of Lung
| Article | Year |
|---|---|
Innovative schedule of oral idarubicin in elderly patients with metastatic breast cancer: comprehensive results of a phase II multi-institutional study with pharmacokinetic drug monitoring.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Chromatography, High Pressure Liquid; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Idarubicin; Liver Neoplasms; Lung Neoplasms; Soft Tissue Neoplasms | 2006 |
Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Formamides; Germanium; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Prognosis; Random Allocation; Remission Induction; Spiro Compounds | 1989 |
Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer.
Topics: Administration, Oral; Aged; Carcinoma, Small Cell; Clinical Trials as Topic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Kinetics; Lung Neoplasms; Male; Middle Aged; Pilot Projects | 1987 |
19 other study(ies) available for idarubicin and Cancer of Lung
| Article | Year |
|---|---|
A Case of Granulocytic Sarcoma of the Lung in Acute Myeloid Leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Remission Induction; Sarcoma, Myeloid | 2019 |
Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin.
Topics: Antibiotics, Antineoplastic; Caco-2 Cells; Cell Survival; Cellulose; Chitosan; Cyclodextrins; Drug Carriers; Humans; Idarubicin; L-Lactate Dehydrogenase; Lung Neoplasms; Nanoparticles; Nanotechnology; Particle Size; Polyethylene Glycols; Tumor Cells, Cultured | 2015 |
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin | 2010 |
Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adsorption; Antibiotics, Antineoplastic; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; HT29 Cells; Humans; Idarubicin; Kinetics; Lung Neoplasms; Microscopy, Confocal; Nanoparticles; Nanotechnology; Particle Size; Polyvinyl Alcohol; Protein Binding; Pterins; Solubility; Starch; Surface-Active Agents; Technology, Pharmaceutical | 2011 |
Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Daunorubicin; Digestive System; Drug Evaluation; Heart; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Middle Aged | 1984 |
Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Topics: Animals; Antineoplastic Agents; Daunorubicin; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental | 1983 |
Relationships among tumor responsiveness, cell sensitivity, doxorubicin cellular pharmacokinetics and drug-induced DNA alterations in two human small-cell lung cancer xenografts.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Southern; Carcinoma, Small Cell; Cell Line; Cell Transformation, Neoplastic; DNA Topoisomerases, Type II; DNA, Single-Stranded; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Idarubicin; Lung Neoplasms; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Proteins | 1990 |
Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Ly; Antigens, Neoplasm; Idarubicin; Immunotherapy; Immunotoxins; Kidney Neoplasms; Lung Neoplasms; Lymphoma; Mice; Neoplasm Metastasis; Survival Analysis; Thymus Neoplasms | 1991 |
Phase II study of 4-demethoxydaunorubicin in previously untreated extensive disease non-small cell lung cancer.
Topics: Adult; Aged; Biological Availability; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged | 1990 |
Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacology.
Topics: Adult; Aged; Digestive System Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Half-Life; Hematologic Diseases; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged; Urinary Bladder Neoplasms | 1990 |
Phase II study of idarubicin in extensive-disease non-small-cell lung cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged | 1989 |
Testing new drugs in untreated small cell lung cancer may prejudice the results of standard treatment: a phase II study of oral idarubicin in extensive disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Daunorubicin; Drug Evaluation; Humans; Idarubicin; Lung Neoplasms; Middle Aged; Neoplasm Metastasis | 1987 |
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC).
Topics: Administration, Oral; Aged; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged | 1988 |
A phase II trial of oral 4'demethoxydaunorubicin (DMDR) in inoperable non small cell lung cancer.
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged | 1988 |
Phase II trials of idarubicin, a new anthracycline.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged | 1987 |
Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxo
Topics: Antibiotics, Antineoplastic; Carcinoma, Small Cell; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Idarubicin; Lung Neoplasms; Mitoxantrone; Naphthacenes; Tumor Stem Cell Assay | 1987 |
Method for the determination of 4-demethoxydaunorubicin, its quinone and hydroquinone metabolites in human plasma and urine by high-performance liquid chromatography.
Topics: Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Daunorubicin; Humans; Hydroquinones; Idarubicin; Lung Neoplasms; Quinones | 1987 |
Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Blood; Carcinoma, Bronchogenic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Lung Neoplasms; Male; Middle Aged | 1986 |
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Male; Middle Aged | 1985 |